AdvisorShares Psychedelics ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.99
資產淨值: 19.30
成立日期: 15/09/2021
 
分析
市值分佈:
36.44%
大市值
23.26%
中市值
33.00%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:09) 總持有投資項目: 25  
0%
 
100%
     10大 (67.30%)
代號 名稱 佔比% ▼ 持有日期
DFTXDefinium Therapeutics Inc11.9930/10/2026
CMPSCOMPASS Pathways Plc11.6630/10/2026
HELPHelus Pharma Inc8.3930/10/2026
LLYEli Lilly & Co6.1130/10/2026
ABBVABBVIE5.4930/10/2026
NBIXNeurocrine Biosciences5.1230/10/2026
RLMDRelmada Therapeutics5.0630/10/2026
DRUGBright Minds Biosciences4.6230/10/2026
STIMNeuronetics4.5030/10/2026
JNJJohnson & Johnson4.3530/09/2026
GHRSGH Research PLC4.2230/10/2026
ANROAlto Neuroscience3.7730/10/2026
SPTXSeaport Therapeutics, Inc.3.6130/09/2026
SUPNSupernus Inc3.3730/10/2026
NRXPNRX Pharmaceuticals3.0030/10/2026
NEUPNeuphoria Therapeutics Inc1.9530/10/2026
PBMPsyence Biomedical Ltd.1.8830/10/2026
OPTHOptimi Health Corp.1.4430/10/2026
IXHLIncannex Healthcare Inc.0.8730/10/2026
NUMIFNuminus Wellness Inc.0.4230/10/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.